Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid in relapsed/refractory NHL, HL, and CLL
NCT01016990Phase 2Unknown
- Sponsor
- Auxilio Mutuo Cancer Center
- Start
- Aug 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), chronic lymphocytic leukemia (CLL), sponsored by Auxilio Mutuo Cancer Center. Status: unknown.
02
Drugs
valproic acid
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01016990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016990.